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Sensitized murine thymus-derived (T) lymphocytes possess the preferential ability 
to recognize extrinsic antigens on H-2 syngeneic cells (1). However, the T-cell 
repertoire also includes the capacity to recognize H-2 alloantigens (2). Because a 
relatively high proportion of cytotoxic T-cell precursors recognize H-2 alloantigens 
(3), the possibility exists that a portion of this alloreactivity includes clones of T cells 
that recognize extrinsic antigens in the context of H-2 allodeterminants. To determine 
whether there exist clones of T cells that can recognize antigens in the context of H- 
2 allodeterminants (antigen H-2 aUospecific recognition) in an animal, we utilized 
animals rendered neonatally tolerant of H-2 alloantigens in which the degree of 
chimerism is exceedingly low. By eliminating the H-2 alloreactivity, we are able to 
demonstrate that cytotoxic T lymphocytes of host origin recognize minor histocom- 
patibility (H) x alloantigens on the tolerated H-2 allogeneic cells. 
Materials and Methods 
Animals. All mice were produced and maintained in our colonies at the University of Texas 
Health Science Center at Dallas, Dallas, Texas. Neonatally tolerant animals were produced by 
a method previously described (4). Briefly, 15 × 106 semiallogeneic bone marrow and spleen 
cells were inoculated i.v. within 24 h of birth. Animals were assayed for tolerance at 8 wk of age 
by the application of an orthotopic skin graft identical to the donor of the tolerizing inoculum. 
Immunization Protocols. Mice were sensitized against minor H-antigens by i.p. inoculation of 
50 × 108 spleen cells. 3 wk to 3 mon later, the recipients were killed, their spleen cells were 
placed in culture with 3,000-rad-irradiated stimulator cells, and cytotoxic T-cell activity was 
assayed 5 d later. 
Cytotoxicity Assay. This procedure has been described in detail in a previous communication 
(5). Data is expressed as the net isotope release, which equals the percentage of 51Cr release 
from target cells in the presence of immune cells minus the percentage of ~lCr release from 
target cells in the presence of control cells. Control cells represent cultures lacking stimulator 
cells. 
Results 
Minor H-Antigens Presented on Tolerated Haplotype Induce T-Effector Cells Restricted to 
Tolerated Haplotype. Strong alloreactivity to an unrelated H-2 haplotype in normal 
animals precludes identifying reactivity to minor H-antigens in an H-2-allogeneic 
context. Therefore, adult B10.A (H-2 a) animals, rendered tolerant to H-2 f antigens 
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TABLE  I 
B I O.A Effector Cells Tolerant of B l O.M Recognize Minor H-Antigens on H-2 Allogeneic Cells 
Immu- 
Line  Responder nization  Target cells 
Minor-  H-2-re-  H anti-  gion shar- 
gen in-  ing be- 
compat-  tween  tar- 
ibility 
between  get cells 
and cells 
re-  used for 
sponder  immuni- 
and tar-  zation  get cells 
Net 51Cr release* (effec- 
tor-to-target cell ratio) 
100:1  50:1  10:1 
1  BI0.M  A.CA  A.CA(KtDt)$  yes  K  D 
2  A.SW(KSD  ~  )  yes 
3  A(KkD a)  yes 
4  A.TFRI(KSD t)  yes  -- D 
5  B10.M(llR)(KfD a)  no  K  -- 
6  B10.A  toler-  A.CA  A.CA  yes  K  D 
7  ant to  A.SW  yes 
8  B10.M  A  yes 
9  A.TFR l  yes  -- D 
10  B10.M(llR)  no  K  -- 
11  B10.M  no  K  D 
31.1  18.9  4.7 
0.1  -0.2  -0.2 
2.5  0.7  0.5 
28.3  19.4  4.9 
1.5  1.2  2.5 
18.8  10.4  2.5 
-0.2  0.9  -0.1 
3.0  0.9  -0.2 
13.8  8.9  2.9 
-0.4  0.l  1.0 
-1.3  -1.7  -0.6 
12  B10.A  B10.M  B10.M  no  K  D  22.5  15.5  4.7 
* SlCr release from target cells in the presence of nonimmune (control) effector cells 
12%. 
"~ H-2K and H-2D alleles. 
ranged from 8.9 to 
by neonatal inoculation of (B 10.A ×  B10.M)F1 spleen cells, were inoculated i.p. with 
A.CA (H-2 f)  spleen cells. Although B10.M and A.CA share the H-2 [ haplotype, they 
have different alleles at  multiple minor H-loci representing the  difference between 
C57BL/10 and A strain background genes. 3 wk to 3 mon after in vivo inoculation of 
the H-2t-tolerant B10.A animals with A.CA lymphoid cells, spleen cells from these 
mice were cocultured with irradiated A.CA spleen cells and subsequently tested for 
cytotoxic activity against a  panel of target cells. As a positive control, normal B 10.M 
animals were sensitized with A.CA spleen cells and the resultant cytotoxic effector 
cells were tested against the same panel of targets. 
B10.M  animals sensitized against minor H-antigen disparate spleen cells  (A.CA) 
generate a cytotoxic effect against A.CA target cells (line 1, Table I). This response is 
1-1-2 restricted in that H-2-incompatible target cells bearing the appropriate minor H- 
antigens are not lysed (lines 2 and 3); whereas a cytotoxic effect is observed if only the 
H-2D f  region is shared between the stimulator and target cell (line 4).  B10.M(11R) 
target cells are not lysed because they lack the A strain background minor H-antigens 
(line 5). 
B 10.A animals tolerant to B 10.M, sensitized in vivo and boosted in vitro with A.CA 
cells, display a strong cytotoxic effect against A.CA target cells (line 6). This response 
is H-2 restricted to the same extent as that observed when testing the B10.M spleen 
ceils.  That  is,  H-2-incompatible target  cells are  not  lysed  (lines 7  and 8),  whereas 
target cells sharing only the H-2D f region with the stimulator cells are lysed (line 9). JAMES FORMAN AND J.  WAYNE  STREILEIN  1003 
TAnLE  II 




Cells  ing be-  Net SXCr Release* (ef- 
Cells  used for  tween  lector-to-target cell ra- 
Line  Responder  used for  in vitro  Target cells  cells used  tio) 
in vivo  for in vi-  chal-  tro thai-  100:1  50:1  10:1  priming  lenge  lenge and 
target 
cells 
1  BI0.A  tolerant  A.CA  A.CA  A.CA  K  D  28.0  28.3  12.5 
2  to B10.M  A  -0.6  1.3  0.9 
3  C3H(/~Dk):~  2.2  2.9  3.6 
4  C3H.SW(KbD b)  0.5  0.4  0.4 
5  B10.A tolerant  A.CA  A  A  K  D  35.3  27.2  11.7 
6  to B10.M  A.CA  1.0  0.6  3.4 
7  C3H  K  --  16.8  13.0  3.8 
8  C3H.SW  0.5  0.7  1.8 
* SXCr release from target cells in the presence of nonimmune  (control) effector cells ranged from  10.3 to 
21.6%. 
H-2K and H-2D alleles. 
B10.M(I IR) target cells lacking the minor H-antigens of the A strain background are 
not lysed (line 10). These data also demonstrate that the H-2t-tolerant B 10.A animals 
do  not  generate  anti-H-2  killer-cell activity  against  B10.M  target  cells  (line  11); 
whereas nontolerant  animals do generate such activity (line  12). Thus,  a  significant 
amount of specific cytotoxic T-cell activity can be generated in B 10.A animals tolerant 
to H-2  f antigens when  these animals are sensitized against minor H-antigens in the 
context of the tolerated H-2-allogeneic haplotype. 
Minor H-Antigens Presented on the Tolerated Haplotype Induce T-Effector Cells Restricted to 
Host Haplotype.  Bevan (6) has demonstrated that minor H-antigens presented on H- 
2 semiallogeneic cells may be used to cross prime mice in vivo so that the antigen can 
be  presented on  the  allogeneic H-2 haplotype. In  these  experiments, we  wished to 
determine whether  animals  tolerant  to  an  H-2  haplotype could  be  presented  with 
minor H-antigens on the tolerated haplotype so that  the antigens could cross-prime 
and restrict for the host haplotype. B 10.A animals tolerant to B 10.M were inoculated 
in vivo with A.CA lymphoid cells. When spleen cells from these tolerant animals were 
later cultured  in  vitro with  A.CA cells, a  cytotoxic response was  generated  against 
A.CA, but not H-2-incompatible target ceils (Table II, lines  1-4), in agreement with 
the  data  shown  in Table  I.  Furthermore,  when  freshly harvested  spleen  cells were 
challenged in vitro with A  strain spleen cells, the cytotoxic effect generated was now 
restricted to KkD a target cells, including C3H, which indicates that the A  and C3H 
strains share some minor H-alleles (lines 5 and 7). Importantly, A.CA cells and other 
H-2-incompatible  target  cells  bearing  the  appropriate  minor  H-antigens  were  not 
lysed (lines 6 and 8). Thus, these results indicate that minor H-antigens presented on 
cells  of an  allogeneic  H-2  haplotype  can  prime  the  animal  for  minor  H-antigen 
recognition on the host's H-2 haplotype. 1004  ANTIGEN H-2 ALLOSPECIFIC RECOGNITION 
TABLE III 
Minor H-Antigens Presented  on Host Haplotype Fail to Induce T Effector Cells Restricted to Tolerated 
Haplotype 
H-2-region 
Cells  sharing be-  Cells 
Line  Responder  used for  used for  Target  tween cells  Net 51Cr release* (effec- 
in vivo  in vitro  cells  used for in  tor-to-target cell ratio) 
chal-  vitro chal- 
priming  lenge  lenge and  100:1  50:1  10:1 
target cells 
1  BI0.A  tolerant  to  A  A  A  K  D  15.8  8.5  2.9 
B10.M 
2  A.CA  --0.4  -3.5  -  1.0 
3  B10.A tolerant  to  A  A.CA  A.CA  K  D  -3.2  -1.1  -0.3 
B10.M 
4  A  -1.1  -1.7  0 
* S~Cr release from A and A.CA target cells in the presence of nonimmune  (control) effector cells was 20.0 
and 24.4%, respectively. 
Minor H-Antigens Presented on Host Haplotype Fail to Induce  T-Effector Cells Restricted to 
Tolerated Haplotype.  We have previously determined that the extent of chimerism in 
animals rendered tolerant as neonates is extremely low (4,  7). Therefore, it would be 
expected that the number of (B 10.A X  B 10.M)FI lymphoreticular cells able to present 
antigen in B 10.A animals tolerant of the B 10.M haplotype would be correspondingly 
low.  In  the  following experiment,  we  determined  whether  the  chimeric  F1  cells in 
tolerant  animals could present  minor H-antigens to the host's T-cell system.  B10.A 
animals  tolerant  of B10.M  were  inoculated  in  vivo  with  A  strain  lymphoid  cells 
followed by reehallenge in vitro with either A or A.CA cells. The specificity of effector 
ceils generated  following in  vitro culture is shown  in Table III. As expected, B 10.A 
animals  tolerant  of B I0.M  and  immunized  with  A  strain cells in  vivo and  in  vitro 
generated cytotoxic effector cells with specificity for A  strain and not for A.CA target 
cells (lines 1 and 2). However, when the tolerant spleen cells were challenged in vitro 
with  A.CA spleen  cells, no  cytotoxic effect  was  observed against  A.CA  target  cells 
(line  3).  Therefore,  minor  H-antigens  presented  on  A  strain  spleen cells cannot  be 
processed in vivo to allow for T-cell recognition of minor H-antigens on the tolerated 
H-2  f haplotype. This  finding suggests that  host  reprocessing of minor H-antigens is 
not a  requisite for sensitization of cytotoxic T  lymphocytes. 
Minor  H-Antigens  Presented on  Tolerated Haplotype  Induce  T-Effector  Cells  Restricted to 
Tolerated  Haplotype.  B10.M  animals were  made tolerant as neonates  to B10.A cells, 
primed  in  vivo and  challenged  in  vitro with  A  strain  lymphoid cells. Their spleen 
cells were then tested against a  panel of target cells (Table IV). The specificity of the 
cytotoxic cells generated  was  restricted  to  H-2-compatible  target  cells  (lines  1-3). 
When the animals were challenged in vitro with A.CA rather than A  strain lymphoid 
cells, a  strong cytotoxic effect was observed against A.CA target cells (lines 4  and 5), 
demonstrating  cross-priming similar to  that  shown  in  Table  II.  Therefore,  B10.M 
animals tolerant to B 10.A also possess T  cells that can recognize minor H-antigens in 
the context of the tolerated H-2 haplotype. JAMES FORMAN AND J.  WAYNE  STREILEIN  1005 
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Cells  Cells  ing be-  tween  Net 5~Cr Release*  used for  cells used  (effector-to-target  Responder  used for  in vitro  Target cells  for in vi-  cell ratio)  in vivo  chal- 
tro chal- 
priming  lenge  lenge and  100:1  50: l  10:1 
target 
cells 
1  BI0.M tolerant to  A  A  A  K  D  33.4  24.6  9.8 
B10.A 
2  A.CA  2.3  0.4  0.9 
3  A.TH (KSDa):]:  -- D  32.2  24.0  10.2 
4  B 10.M tolerant to  A  A.CA  A.CA  K  D  39.3  32.1  11.2 
BI0.A 
5  A  6.0  4.7  3.4 
* 51Cr release from target cells in the presence of nonimmune  (control) effector cells ranged from  13.8 to 
15.8%. 
H-2K and H-2D alleles. 
Discussion 
The  data  in  this  report  demonstrate  that  animals  rendered  tolerant  as neonates 
possess a  significant number of cytotoxic T-cell precursors that can recognize minor 
H-antigens in the context of the allogeneic H-2 haplotype to which they were rendered 
tolerant. Secondly, because the specificity of the effector cells generated are restricted 
by the H-2 haplotype of the cells used for the in vitro challenge, it is concluded that 
two different sets of cytotoxic effector cells co-exist in tolerant  animals.  Because we 
cannot find cytotoxic T  cells (or their precursors) that can recognize the tolerated H- 
2  alloantigens themselves  in  these  animals,  it  is  surprising that  T  cells from  these 
animals that recognize minor H-antigens can be restricted by the H-2 alloantigens to 
which they are tolerant. 
This  situatioa  may  be  explained  by  postulating  that  alloreactive  T  cells  bear 
receptors  with  a  spectrum  of avidities for  H-2  antigens.  In  the  tolerance  protocol, 
high-avidity receptor bearing T  cells are deleted so that only those with low-avidity 
receptors remain. These putatively low-avidity-receptor clones could bind alloantigen 
with  high  avidity, however, if the H-2  alloantigen is presented together with minor 
H-antigens. Alternatively, T  cells recognizing minor H-antigens in the context of H- 
2  allodeterminants  could  represent  a  subset  of anti-self clones  that  coincidentally 
cross-react with  minor  H-antigens  along with  the  allo-H-2 determinants,  and  thus 
would not be expected to be affected by the tolerance procedure itself. 
It is very unlikely that  FI cells utilized for the tolerance induction are mediating 
the cytotoxic effects observed because we have previously shown that (a) the extent of 
lymphoid cell chimerism in animals rendered tolerant by this protocol is <5%  (4,  7), 
and  (b)  treatment  of the effector cells with  antiserum  against  the  FI cells does not 
affect the cytotoxic response (7). 
It  is  possible that  the  activity of the  effector ceils  from  B10.A  mice  tolerant  to 1006  ANTIGEN H-2 ALLOSPECIFIC RECOGNITION 
B 10.M that were sensitized and tested against A.CA is H-2 unrestricted and directed 
against Qa-Tla antigens  (8)  rather than A  strain minor H-antigens restricted by H- 
2K  t or H-2D  f. This possibility is unlikely, however, because (a) both B 10.M and A.CA 
have the same alleles at the Qa-Tla loci that control antigens that are recognized by 
cytotoxic  T  cells,  and  (b)  attempts  to  demonstrate  H-2-unrestricted  anti-Qa-Tla 
effector cell activity by cross-sensitization of B 10.M animals with A.CA cells and vice 
versa has yielded negative results (8;  and James Forman, unpublished results). 
Bevan  (6)  has  demonstrated  that  cross-priming  occurs  in  vivo  when  minor  H- 
antigens  are presented  on  an H-2 haplotype that  is different  than  that  used  for in 
vitro boosting. Therefore, it is possible that minor H-antigens have to be reprocessed 
on host cells to generate cytotoxic effector cells. However, our data demonstrate that 
this is not  a  requirement.  Thus,  B10.A  animals tolerant  of B10.M  when primed in 
vivo  and  boosted  in  vitro  with  A.CA  cells  generate  H-2f-restricted  anti-minor-H- 
antigen effector cells. It could be argued that A strain minor H-antigens are processed 
on  the  small  number of (B10.A  ×  B10.M)F1  cells residing  in  the  tolerant  animals 
(<5%).  If this occurs, then it would  be expected that  inoculation  of A  strain spleen 
cells into the same tolerant animals should allow for cross-priming, so that boosting 
in  vitro  with  A.CA  stimulator  cells  would  result  in  H-2f-restricted  anti-minor-H- 
antigen  cytotoxic  effector cells.  However,  this  does  not  occur,  even  though  cross- 
priming does occur in the opposite direction.  Therefore, we conclude that cytotoxic 
T-cell precursors can recognize minor H-antigens directly on the donor-cell inoculum 
without a  requirement for reprocessing. 
It is becoming more clear that the ability of T  cells to recognize antigens on H-2- 
allogeneic cells is widespread and thus contrasts with the initial reports of Zinkernagel 
et  al.  (9),  who did  not  find  cytotoxic T  cells in  radiation  chimeras that  recognize 
antigen in the context of I-I-2 allodeterminants. Our data extend our previous findings 
which  showed  that  trinitrophenyl  could  be recognized  on  H-2-allogeneic tolerated 
cells  (7),  and  are  in  agreement  with  those  of Matzinger  and  Mirkwood  (10)  who 
demonstrated  the  recognition  of  minor  H-antigens  in  fully  allogeneic  radiation 
chimeras.  Blanden  and Andrew  (11)  also found that  a  certain  portion of T  cells in 
radiation  chimeras could recognize ectromelia virus on H-2-allogeneic cells.  Experi- 
ments  are  now  in  progress  to  determine  whether  T-cell  recognition  of minor  H- 
antigens in the context of H-2 allodeterminants has in vivo relevance as demonstrated 
by the  rejection  of skin  allografts  bearing  minor  H-antigens  in  the  context  of the 
tolerated H-2 haplotype. 
Summary 
B10.A animals were rendered tolerant to B10.M spleen cells by injection of (B10.A 
×  B10.M)F1 cells into neonates. Adult animals accepted B10.M skin grafts and failed 
to  generate  cytotoxic  effector  cells  in  vitro  against  B10.M  H-2  antigens.  In  vivo 
inoculation of tolerant animals with A.CA spleen cells, followed by in vitro challenge 
with  similar  cells,  resulted  in  the  generation  of cytotoxic  effector  cells  that  had 
specificity for the A strain minor histocompatibility (H)-antigens in the context of the 
H-2  f haplotype. If these animals were boosted in vitro with A strain spleen cells, cross- 
priming could be demonstrated, whereby the cytotoxic effect was restricted by the H- 
2 a haplotype. These data indicate that at least two sets of T  cells co-exist in tolerant 
animals, one capable of recognizing antigens in the context of the host H-2 haplotype, JAMES FORMAN AND J.  WAYNE  STREILEIN  1007 
and the other able to recognize antigens in the context of the tolerated H-2-allogeneic 
haplotype. 
Because tolerant animals inoculated with A-strain spleen cells in vivo and boosted 
in vitro with A.CA spleen cells failed to generate a  cytotoxic effect against A.CA, it is 
unlikely that minor H-antigens need to be processed by host lymphoreticular ceils. 
We wish to thank Julia Tsan for her excellent technical assistance. 
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